Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric carboxymaltose maintenance versus placebo in iron deficiency associated with inflammatory bowel disease
2008-003591-22Phase 3Completed
- Sponsor
- CSL Vifor
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in iron deficiency anemia (IDA), anaemia and inflammatory bowel disease (IBD) comparing Ferric carboxymaltose maintenance with Placebo (2 arms). Started Aug 2008; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)anaemiainflammatory bowel disease (IBD)
Beyond the preview
Go deeper on 2008-003591-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003591-22.